Evidence map›Paper›PMID 35130618›Full record

ArticleActa biochimica et biophysica Sinica2022

Aberrant expression of the extracellular matrix component Biglycan regulated by Hedgehog signalling promotes colorectal cancer cell proliferation.

Shaopeng Zeng, Feifei Zhou, Yiqing Wang, Zhenyu Zhai, Linlin Xu, Hailong Wang, Xinping Chen, Shiwen Luo, Minzhang Cheng

Open access · greenAbstract read
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shaopeng ZengCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Feifei ZhouCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Yiqing WangCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhenyu ZhaiCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Linlin XuCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Hailong WangCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Xinping ChenDepartment of Obstetrics & Gynecology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Shiwen LuoCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Minzhang ChengCenter for Experimental Medicine, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Nanchang University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hedgehog (Hh) signalling plays essential roles in regulating embryonic development and contributes to tumour initiation, growth and progression in multiple cancers. The detailed mechanism by which Hh signalling participates in tumour growth warrants thorough study, although several downstream target genes have been identified. Herein, a set of novel targets of Hh signalling was identified in multiple types of tumour cells via RNA-Seq analysis. Among these targets, the expression regulation and oncogenic function of the extracellular matrix component biglycan (BGN) were investigated. Further investigation verified that Hh signalling activates the expression of BGN via the transcription factor Gli2, which directly binds to the promoter region of BGN. Functional assays revealed that BGN facilitates tumour cell growth and proliferation in colorectal cancer (CRC) cells, and xenograft assays confirmed that BGN also promotes tumour growth . Moreover, analysis of clinical CRC samples showed that both the protein and mRNA levels of BGN are increased in CRC tissues compared to those in adjacent tissues, and higher expression of BGN is correlated with poorer prognosis of CRC patients, further confirming the function of BGN in CRC. Taken together, aberrantly activated Hh signalling increases the expression of BGN, possibly regulates the extracellular matrix, and thereby promotes tumour growth in CRC.

Indexed as

Colorectal NeoplasmsHedgehog ProteinsBiglycanCell ProliferationExtracellular MatrixFemaleHumansPregnancyBiglycanHedgehog Proteinsbiglycancolorectal cancerHedgehog signallingRNA-Seq

Identifiers

PMID35130618
PMCPMC9909327
OpenAlexW4200451466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.